Australian Clinical Labs Ltd (AU:ACL) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Australian Clinical Labs Ltd has announced a daily buy-back of its ordinary fully paid securities, acquiring 125,000 shares on the previous day. This move is part of an ongoing buy-back strategy, with the company having repurchased a total of 1,080,864 shares before the previous day. Investors may find this buy-back activity indicative of the company’s confidence in its stock value.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Deutsche Bank Pounds the Table on Broadcom Stock
- ‘Get in for 2025 Gains,’ Says Cowen on Amazon Stock
- Top Analyst Sets the Stage for Nike Stock Ahead of Earnings
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
